Blue Bell Private Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Hold
148
﹤0.01% 531
2026
Q1
$20.6K Hold
148
﹤0.01% 510
2025
Q4
$18.2K Hold
148
﹤0.01% 500
2025
Q3
$16.4K Hold
148
﹤0.01% 501
2025
Q2
$16.4K Hold
148
﹤0.01% 486
2025
Q1
$16.6K Hold
148
﹤0.01% 476
2024
Q4
$13.7K Sell
148
-33
-18% -$2.97K ﹤0.01% 467
2024
Q3
$15.2K Buy
181
+33
+22% +$2.52K ﹤0.01% 484
2024
Q2
$10.2K Sell
148
-4
-3% -$267 ﹤0.01% 516
2024
Q1
$11.1K Sell
152
-55
-27% -$4.23K ﹤0.01% 511
2023
Q4
$16.8K Hold
207
﹤0.01% 446
2023
Q3
$15.5K Hold
207
﹤0.01% 384
2023
Q2
$16K Buy
207
+102
+97% +$8.13K ﹤0.01% 372
2023
Q1
$8.71K Hold
105
﹤0.01% 392
2022
Q4
$9.01K Hold
105
﹤0.01% 384
2022
Q3
$6K Sell
105
-15
-13% -$946 ﹤0.01% 439
2022
Q2
$7K Sell
120
-50
-29% -$3.1K ﹤0.01% 440
2022
Q1
$10K Hold
170
﹤0.01% 409
2021
Q4
$12K Buy
+170
New +$11.7K ﹤0.01% 376
2016
Q4
Sell
-100
Closed -$8K 320
2016
Q3
$8K Sell
100
-534
-84% -$43.4K ﹤0.01% 364
2016
Q2
$53K Buy
634
+2
+0.3% +$177 0.03% 209
2016
Q1
$58K Buy
632
+281
+80% +$25.3K 0.04% 208
2015
Q4
$36K Buy
351
+1
+0.3% +$104 0.02% 248
2015
Q3
$34K Hold
350
0.02% 260
2015
Q2
$41K Buy
350
+50
+17% +$5.46K 0.02% 242
2015
Q1
$29K Hold
300
0.02% 272
2014
Q4
$28K Buy
300
+200
+200% +$20.7K 0.02% 278
2014
Q3
$11K Buy
+100
New +$9.79K 0.01% 381

Other funds holding GILD

Blue Bell Private Wealth Management's GILD Position: Q2 2026 in Review

Blue Bell Private Wealth Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 148 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #531.

Blue Bell Private Wealth Management first reported a position in GILD in Q3 2014 and has held it in 28 quarters since. The position peaked at $58K in Q1 2016. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Blue Bell Private Wealth Management held 148 shares of Gilead Sciences worth $18.7K as of Q2 2026.
  • Blue Bell Private Wealth Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up ﹤0.01% of Blue Bell Private Wealth Management's portfolio in Q2 2026, its #531 holding.
  • Blue Bell Private Wealth Management first reported a position in Gilead Sciences in Q3 2014 and has held it in 28 quarters since.
  • Blue Bell Private Wealth Management's Gilead Sciences position peaked at $58K in Q1 2016.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Blue Bell Private Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.